Skip to main content

Table 3 Multivariate survival analysis for disease-free survival and overall survival

From: Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients

   DFS   OS   
HR 95% CI P HR 95% CI P
Lepidic predominant (yes/no) 0.756 0.723-1.012 0.101 0.876 0.597-1.986 0.742
Micropapillary predominant (yes/no) 1.473 1.041-1.786 0.048 1.342 0.764-1.987 0.214
Solid predominant (yes/no) 1.210 0.987-1.978 0.076 1.229 0.746-2.158 0.435
lymphatic and/or vessel invasion (yes/no) 1.153 0.979-2.143 0.079 1.075 0.774-3.547 0.843
  1. DFS, disease-free survival; OS, overall survival.